JBM HEALTHCARE(02161),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02161 JBM HEALTHCARE

Closed 12-19 15:59:28

2.600

+0.000

0.00%

High2.630	Low2.580	Vol728.00K
Open2.600	D1 Closing2.600	Amplitude1.92%
Mkt Cap2.14B	Tradable Cap2.14B	Total Shares822.00M
T/O1.89M	T/O Rate0.09%	Tradable Shares822.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02161","market":"HK","secType":"STK","nameCN":"JBM HEALTHCARE","latestPrice":2.6,"timestamp":1766131168013,"preClose":2.6,"halted":0,"volume":728000,"delay":0,"floatShares":822000000,"shares":822000000,"eps":0.223222,"marketStatus":"Closed","change":0,"latestTime":"12-19 15:59:28","open":2.6,"high":2.63,"low":2.58,"amount":1890220,"amplitude":0.019231,"askPrice":2.63,"askSize":10000,"bidPrice":2.6,"bidSize":30000,"shortable":0,"etf":0,"ttmEps":0.24623,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"listingDate":1612454400000,"exchange":"SEHK","adjPreClose":2.6,"dividendRate":0.081731,"openAndCloseTimeList":[[1766107800000,1766116800000],[1766120400000,1766131200000]],"volumeRatio":1.685133,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02161/tweets","defaultTab":"tweets","newsList":[{"id":"2590595638","title":"JBM (Healthcare) H1 Operating Profit HKD 150.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2590595638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590595638?lang=en_us&edition=fundamental","pubTime":"2025-12-11 16:31","pubTimestamp":1765441908,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nPLX38D10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1606","02161"],"gpt_icon":0},{"id":"2589388437","title":"Asian Penny Stocks To Watch In December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589388437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589388437?lang=en_us&edition=fundamental","pubTime":"2025-12-08 06:01","pubTimestamp":1765144907,"startTime":"0","endTime":"0","summary":"As global markets keenly await the final Federal Reserve meeting of the year, Asian markets are navigating a landscape marked by mixed economic signals and cautious optimism. Amid these conditions, penny stocks—often smaller or newer companies with potential for significant growth—continue to capture investor interest due to their affordability and growth prospects. While the term 'penny stocks' might seem outdated, these investments can still represent valuable opportunities when backed by...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/cn/materials/szse-002004/huapont-life-sciencesltd-shares/news/asian-penny-stocks-to-watch-in-december-2025-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/cn/materials/szse-002004/huapont-life-sciencesltd-shares/news/asian-penny-stocks-to-watch-in-december-2025-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00806","SCT.NZ","SG9999013486.USD","LU1242518857.USD","SGXZ58947870.SGD","LU0516423091.SGD","SG9999004360.SGD","SG9999013460.SGD","LU0082770016.SGD","BK1156","BK8040","01346","LU1242518931.SGD","LU0516422366.SGD","SG9999003826.SGD","SG9999000343.SGD","LU0979878070.USD","BK8052","BK8065","SG9999000475.SGD","SGXZ24219693.SGD","02161","5UL.SI","LU0516423174.USD","SG9999014484.SGD","LIC.NZ","SG9999002679.SGD","SG9999014492.USD","LU0620787316.HKD","02283","BK6065","SGXZ27511609.SGD","SG9999013478.USD","BK6504","LU0516422440.USD","SG9999016042.SGD","SGXZ43160589.SGD","LU0082770016.USD","002004","LU0164939612.USD","LU0516422952.EUR","5TP.SI"],"gpt_icon":1},{"id":"1190868845","title":"JBM (HEALTHCARE) LIMITED (02161) Announces November 2025 Monthly Equity Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1190868845","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190868845?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:06","pubTimestamp":1764579991,"startTime":"0","endTime":"0","summary":"JBM (HEALTHCARE) LIMITED (02161) released a monthly return for its equity movements as of 30 November 2025. The authorized share capital remains at 5,000,000,000 ordinary shares with a par value of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161"],"gpt_icon":0},{"id":"2584985258","title":"JBM (Healthcare)'s Profit Jumps 20% in Fiscal H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2584985258","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584985258?lang=en_us&edition=fundamental","pubTime":"2025-11-18 14:25","pubTimestamp":1763447148,"startTime":"0","endTime":"0","summary":"JBM   recorded a 20% rise in attributable profit in six months ended Sept. 30 to HK$115 million from HK$95.9 million in the year-ago period, a Monday Hong Kong bourse filing said.Shares of the drug company were up nearly 5% in Tuesday afternoon trading.Earnings per share were HK$0.1412 in the half year, up from HK$0.1163 in the corresponding period of the last year.Revenue rose 7.7% to HK$429.6 million in the interim period from HK$399 million a year prior, driven by a strong performance in the branded medicine and proprietary Chinese medicine segments.The firm attributed the higher profit to a rise in profit from operations.The company declared an interim dividend of HK$0.0975 per ordinary share, payable Dec. 17 to shareholders of record on Dec. 3.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02161","BK1606","XBI","XLV","BK4588","BK4137","BK1191","HCSG","BK4585","LABU","LU0029874061.USD","LU0128526141.USD","BK4581"],"gpt_icon":0},{"id":"1127455668","title":"Stock Track | JBM Healthcare Soars 5.19% After Announcing Strong H1 Results and Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1127455668","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127455668?lang=en_us&edition=fundamental","pubTime":"2025-11-18 09:32","pubTimestamp":1763429576,"startTime":"0","endTime":"0","summary":"JBM Healthcare (02161.HK) saw its stock price surge 5.19% in Tuesday's trading session following the release of its impressive half-year financial results. The healthcare company reported robust...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02161"],"gpt_icon":0},{"id":"1132758072","title":"Stock Track | JBM Healthcare Soars 5.19% Following Strong H1 Financial Results and Dividend Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1132758072","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132758072?lang=en_us&edition=fundamental","pubTime":"2025-11-18 09:32","pubTimestamp":1763429576,"startTime":"0","endTime":"0","summary":"JBM Healthcare (2161.HK) saw its stock price surge 5.19% in Tuesday's trading session, following the release of impressive half-year financial results. The healthcare company's strong performance and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02161"],"gpt_icon":0},{"id":"2584678535","title":"BRIEF-JBM (Healthcare) Posts H1 Revenue Of HK$429.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2584678535","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584678535?lang=en_us&edition=fundamental","pubTime":"2025-11-18 01:08","pubTimestamp":1763399304,"startTime":"0","endTime":"0","summary":"BRIEF-JBM  Posts H1 Revenue Of HK$429.6 MlnNov 17  - JBM  Ltd 2161.HK:H1 REVENUE HKD 429.6 MILLIONH1 GROSS PROFIT HKD 253.6 MILLIONINTERIM DIVIDEND HK9.75 CENTS PER SHAREH1 NET INCOME HKD 115 MILLIONFurther company coverage: 2161.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nPLX21EB3B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161","BK1606","BK1191"],"gpt_icon":0},{"id":"1181837481","title":"JBM HEALTHCARE (02161) to Distribute Interim Dividend of HK$0.0975 per Share on December 17","url":"https://stock-news.laohu8.com/highlight/detail?id=1181837481","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181837481?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:44","pubTimestamp":1763376253,"startTime":"0","endTime":"0","summary":"JBM HEALTHCARE (02161) announced that the company will distribute an interim dividend of HK$0.0975 per share on December 17, 2025.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02161","BK1606"],"gpt_icon":0},{"id":"1182754508","title":"JBM HEALTHCARE (02161) Reports Interim Results: Profit Attributable to Equity Holders Rises 20.0% YoY to Approximately HK$115 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1182754508","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182754508?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:40","pubTimestamp":1763376026,"startTime":"0","endTime":"0","summary":"JBM HEALTHCARE (02161) announced its interim results for the six months ended September 30, 2025. Revenue reached approximately HK$430 million, representing a year-on-year increase of 7.7%. Profit...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","02161","BK1191"],"gpt_icon":0},{"id":"2584644366","title":"JBM (Healthcare) Ltd. announces interim dividend of HKD 0.0975 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2584644366","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584644366?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:35","pubTimestamp":1763375746,"startTime":"0","endTime":"0","summary":"JBM  Ltd. has announced an interim dividend of HKD 0.0975 per share for the six months ended 30 September 2025. This amount reflects the value of the dividend declared for the period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JBM  Ltd. published the original content used to generate this news brief on November 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL5NnZnC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","02161"],"gpt_icon":0},{"id":"2584898644","title":"JBM (Healthcare) H1 Revenue HKD 429.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584898644","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584898644?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:34","pubTimestamp":1763375674,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nPLX21EB3B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02161","BK1191","BK1606"],"gpt_icon":0},{"id":"2584644895","title":"JBM (Healthcare) Ltd -  Interim Dividend HK9.75 Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2584644895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584644895?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:34","pubTimestamp":1763375674,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nPLX21EB3B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02161","BK1606"],"gpt_icon":0},{"id":"1141976052","title":"JBM (Healthcare) Limited (2161 HK) Announces Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1141976052","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141976052?lang=en_us&edition=fundamental","pubTime":"2025-11-05 08:22","pubTimestamp":1762302163,"startTime":"0","endTime":"0","summary":"JBM (Healthcare) Limited (2161 HK) has scheduled a board meeting on 17 November 2025 to consider and approve the interim results for the six months ended 30 September 2025. Plans for an interim...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161"],"gpt_icon":0},{"id":"2581979966","title":"JBM (Healthcare) Ltd. Board to Review Interim Results and Potential Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2581979966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581979966?lang=en_us&edition=fundamental","pubTime":"2025-11-05 08:02","pubTimestamp":1762300976,"startTime":"0","endTime":"0","summary":"JBM  Ltd. will hold a board meeting on Monday, 17 November 2025 to consider and approve the interim results of the company and its subsidiaries for the six months ended 30 September 2025, and to discuss the recommendation of an interim dividend.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JBM  Ltd. published the original content used to generate this news brief on November 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLbrBHxY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161","BK1606","BK1191"],"gpt_icon":0},{"id":"1196367778","title":"JBM (Healthcare) Limited (Stock Code: 02161) Announces Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1196367778","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196367778?lang=en_us&edition=fundamental","pubTime":"2025-11-03 16:51","pubTimestamp":1762159908,"startTime":"0","endTime":"0","summary":"JBM (Healthcare) Limited (02161) reported no change in its authorized share capital for the month ended 31 October 2025, remaining at 5 billion ordinary shares at a par value of HKD 0.01 each. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161"],"gpt_icon":0},{"id":"1172535201","title":"Jacobson Pharma (2633) and JBM (Healthcare) (2161) Announce 2025 Europharm License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1172535201","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172535201?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:02","pubTimestamp":1761649371,"startTime":"0","endTime":"0","summary":"Jacobson Pharma Corporation Limited (stock code: 2633) and JBM (Healthcare) Limited (stock code: 2161) jointly announced approval of the 2025 Europharm License Agreement. Europharm, an indirect...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161"],"gpt_icon":0},{"id":"1174469961","title":"Jacobson Pharma (02633) and JBM Healthcare (02161): ULFERTS and ULFERTS (Hong Kong) Enter into 2025 Licensing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1174469961","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174469961?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:48","pubTimestamp":1761648507,"startTime":"0","endTime":"0","summary":"Jacobson Pharma (02633) and JBM Healthcare (02161) jointly announced that as the 2020 licensing agreement is set to expire on November 30, 2025, ULFERTS and ULFERTS (Hong Kong) entered into the 2025...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161","BK1201","BK1191","BK1606","02633","BK1585","01711"],"gpt_icon":0},{"id":"2578932034","title":"Jacobson Pharma Signs 2025 Europharm License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2578932034","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578932034?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:33","pubTimestamp":1761647593,"startTime":"0","endTime":"0","summary":"Jacobson Pharma Corporation Ltd. and JBM  Limited have jointly announced the signing of the 2025 Europharm License Agreement. The agreement follows the expiration of the previous 2020 License Agreement on 30 November 2025. The new license arrangement is considered by the boards of both companies to be in the ordinary and usual course of business, with terms deemed fair, reasonable, and in the best interests of shareholders. The agreement constitutes a continuing connected transaction under Chapter 14A of the Hong Kong Listing Rules. As the applicable percentage ratios are below 5% but the total considerations exceed HK$3,000,000, the agreements are subject to reporting and announcement requirements but are exempt from circular and independent shareholders' approval requirements. Directors with potential conflicts of interest abstained from voting on the relevant resolutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL89My1M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1191","02633","02161"],"gpt_icon":0},{"id":"2578932037","title":"JBM (Healthcare) Signs 2025 Europharm License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2578932037","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578932037?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:33","pubTimestamp":1761647591,"startTime":"0","endTime":"0","summary":"JBM  Ltd. has announced that Europharm and Europharm HK have entered into the 2025 Europharm License Agreement on 28 October 2025. Under this agreement, Europharm will grant a license to Europharm HK to use a portion of the Factory from 1 December 2025 to 27 January 2028, for a monthly license fee of HK$247,000. The agreement follows the expiration of the previous license on 30 November 2025. The directors of both Jacobson and JBM, including their independent non-executive directors, consider the terms of the agreement to be fair, reasonable, on normal commercial terms, and in the best interests of the companies and their shareholders. Certain directors abstained from voting on the relevant board resolutions to avoid potential conflicts of interest.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL4lxyrS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","02161","BK1191"],"gpt_icon":0},{"id":"1143303106","title":"JBM HEALTHCARE (02161): Xu Hongxi Appointed as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1143303106","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143303106?lang=en_us&edition=fundamental","pubTime":"2025-09-30 16:37","pubTimestamp":1759221443,"startTime":"0","endTime":"0","summary":"JBM HEALTHCARE (02161) announced that Dr. Xu Hongxi has been appointed as a non-executive director, effective from October 2, 2025.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","02161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0299},{"period":"1month","weight":-0.1013},{"period":"3month","weight":-0.1304},{"period":"6month","weight":-0.0273},{"period":"1year","weight":0.509},{"period":"ytd","weight":0.4698}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":-0.0167},{"period":"3month","weight":-0.0394},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.2836},{"period":"ytd","weight":0.2711}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"JBM (Healthcare) Ltd is an investment holding company principally engaged in the development, manufacture and distribution of Chinese medicines. The Company operates its business through three segments. The Branded Medicines segment is engaged in the development, manufacture and distribution of branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment is engaged in the development, manufacture and distribution of registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal or mineral origin customarily or widely used by the Chinese. The Health and Wellness Products segment is engaged in the distribution and sale of supplements, medical consumables and other nonpharmaceutical products for the general health and wellness of consumers.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.082255},{"month":2,"riseRate":0.25,"avgChangeRate":-0.018544},{"month":3,"riseRate":0.2,"avgChangeRate":0.005762},{"month":4,"riseRate":0.2,"avgChangeRate":-0.008582},{"month":5,"riseRate":0.8,"avgChangeRate":0.190045},{"month":6,"riseRate":0.6,"avgChangeRate":0.051663},{"month":7,"riseRate":0,"avgChangeRate":-0.104056},{"month":8,"riseRate":0.4,"avgChangeRate":0.003769},{"month":9,"riseRate":0.6,"avgChangeRate":-0.002512},{"month":10,"riseRate":0.2,"avgChangeRate":-0.043561},{"month":11,"riseRate":0.6,"avgChangeRate":0.130682},{"month":12,"riseRate":0.8,"avgChangeRate":0.142259}],"exchange":"SEHK","name":"JBM HEALTHCARE","nameEN":"JBM HEALTHCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"JBM HEALTHCARE(02161),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest JBM HEALTHCARE(02161) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"JBM HEALTHCARE,02161,JBM HEALTHCARE股票,JBM HEALTHCARE股票老虎,JBM HEALTHCARE股票老虎国际,JBM HEALTHCARE行情,JBM HEALTHCARE股票行情,JBM HEALTHCARE股价,JBM HEALTHCARE股市,JBM HEALTHCARE股票价格,JBM HEALTHCARE股票交易,JBM HEALTHCARE股票购买,JBM HEALTHCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"JBM HEALTHCARE(02161),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest JBM HEALTHCARE(02161) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}